These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31955667)

  • 1. Guideline adherence for the management of emergency department patients with febrile neutropenia and no infection source: Is there room for improvement?
    Jansma B; Vakkalanka P; Talan DA; Negaard B; Faine BA
    J Oncol Pharm Pract; 2020 Sep; 26(6):1382-1389. PubMed ID: 31955667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency department management of chemotherapy related febrile neutropenia: An opportunity to improve care.
    Pettit N; Boadu D; Bischof JJ
    Am J Emerg Med; 2021 Dec; 50():5-9. PubMed ID: 34265732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency Department Management of Patients With Febrile Neutropenia: Guideline Concordant or Overly Aggressive?
    Baugh CW; Wang TJ; Caterino JM; Baker ON; Brooks GA; Reust AC; Pallin DJ
    Acad Emerg Med; 2017 Jan; 24(1):83-91. PubMed ID: 27611638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to practice guidelines for the management of febrile neutropenia in patients undergoing hematopoietic stem cell transplantation: An observational study in a referral center in Iran.
    Ekhtiari Kolour SR; Shahrami B; Kargar M; Taghvaye Masoumi H; Amini S; Vaezi M; Hadjibabaie M; Mohammadi M; Sadeghi K
    J Oncol Pharm Pract; 2023 Jul; 29(5):1112-1118. PubMed ID: 35392730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia.
    Vicente M; Al-Nahedh M; Parsad S; Knoebel RW; Pisano J; Pettit NN
    J Oncol Pharm Pract; 2017 Dec; 23(8):575-581. PubMed ID: 27609336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia.
    Daniels LM; Durani U; Barreto JN; O'Horo JC; Siddiqui MA; Park JG; Tosh PK
    Support Care Cancer; 2019 Nov; 27(11):4171-4177. PubMed ID: 30805726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective analysis of clinical acuity markers on hospital length of stay in patients with febrile neutropenia.
    Johannesmeyer HJ; Seifert CF
    J Oncol Pharm Pract; 2019 Apr; 25(3):535-543. PubMed ID: 29207937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Febrile neutropenia in French emergency departments: results of a prospective multicentre survey.
    André S; Taboulet P; Elie C; Milpied N; Nahon M; Kierzek G; Billemont M; Perruche F; Charpentier S; Clément H; Pourriat JL; Claessens YE
    Crit Care; 2010; 14(2):R68. PubMed ID: 20403164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value-Based Care for Healthy Children With First Episode of Febrile Neutropenia.
    Grandjean-Blanchet C; Le CK; Villeneuve S; Cada M; Beck CE; Science M; Rosenfield D; Ostrow O
    Hosp Pediatr; 2023 Jun; 13(6):536-544. PubMed ID: 37194483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to antibiotics and outcomes in cancer patients with febrile neutropenia.
    Perron T; Emara M; Ahmed S
    BMC Health Serv Res; 2014 Apr; 14():162. PubMed ID: 24716604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents.
    Ahn S; Rice TW; Yeung SJ; Cooksley T
    Support Care Cancer; 2018 May; 26(5):1465-1470. PubMed ID: 29168032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low utilization of vancomycin in febrile neutropenia: real-world evidence from 4 Brazilian centers.
    Ramos JF; Pereira AD; Seiwald MCN; Gandolpho LS; Molla VC; Guaraná M; Nouér SA; Nucci M; Rodrigues CA
    Support Care Cancer; 2023 Nov; 31(12):687. PubMed ID: 37947888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a Pediatric Emergency Medicine Pharmacist, Institutional Guideline, and Electronic Order Set on Empiric Antimicrobial Use for Febrile Neutropenia.
    Aluisio YM; Sanchez AC; Norris KR; Waller J; Campbell CT
    Pediatr Emerg Care; 2024 Feb; 40(2):151-155. PubMed ID: 37440312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febrile Neutropenia: Decreasing Time to Antibiotic Administration in a Community Hospital Emergency Department.
    Bruce SD
    Clin J Oncol Nurs; 2021 Feb; 25(1):23-26. PubMed ID: 33480869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department.
    Coyne CJ; Le V; Brennan JJ; Castillo EM; Shatsky RA; Ferran K; Brodine S; Vilke GM
    Ann Emerg Med; 2017 Jun; 69(6):755-764. PubMed ID: 28041827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency Ambulatory Management of Low-Risk Febrile Neutropenia: Multinational Association for Supportive Care in Cancer Fits-Real-World Experience From a UK Cancer Center.
    Marshall W; Campbell G; Knight T; Al-Sayed T; Cooksley T
    J Emerg Med; 2020 Mar; 58(3):444-448. PubMed ID: 31744709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department.
    Lynn JJ; Chen KF; Weng YM; Chiu TF
    Hematol Oncol; 2013 Dec; 31(4):189-96. PubMed ID: 23303687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of early de-escalation of empiric antimicrobial therapy in acute leukemia patients with febrile neutropenia at a large academic medical center.
    Ly WJ; Brown EE; Pedretti Z; Auten J; Wilson WS
    J Oncol Pharm Pract; 2023 Mar; 29(2):305-310. PubMed ID: 34927495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department.
    Keng MK; Thallner EA; Elson P; Ajon C; Sekeres J; Wenzell CM; Seastone DJ; Gallagher EM; Weber CM; Earl MA; Mukherjee S; Pohlman B; Cober E; Foster VB; Yuhas J; Kalaycio ME; Bolwell BJ; Sekeres MA
    J Oncol Pract; 2015 Nov; 11(6):450-5. PubMed ID: 26220930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of complete blood count parameters to predict poor outcomes in cancer patients with febrile neutropenia presenting to the emergency department.
    Choi A; Park I; Lee HS; Chung J; Kim MJ; Park YS
    Ann Med; 2022 Dec; 54(1):599-609. PubMed ID: 35175159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.